Varaico: Literature-Extracted Genetic Variants

Gene:CFTR
Variant:p.I148T
Back to variants list

CFTR

NM_000492.4:p.I148T

Associated Papers

Prevalence, type, and clinical implications of CFTR variants in bronchiectasis.

Gramegna A et al.

Pulmonology, 2026

General trends in the calnexin-dependent expression and pharmacological rescue of clinical CFTR variants.

Tedman A et al.

Elife, 2025

41379933 (PubMed )
Supplement: elife-107180-supp1.xlsx › CANX_KO_Counts

Cystic fibrosis risk variants confer protection against inflammatory bowel disease.

Yu M et al.

Cell Genomics, 2025

41330381 (PubMed )
Supplement: mmc3.xlsx › Sheet1

Developing a primer for communicating about penetrance, expressivity, and genotype-phenotype correlation of R117H and the poly-T tract in CFTR.

Raraigh KS et al.

Journal of Genetic Counseling, 2025

Characterization of Egyptian cystic fibrosis children including genotypes and phenotypes: A single tertiary center experience.

Fouda EM et al.

Respiratory Medicine, 2025

Efficacy of elexacaftor/tezacaftor/ivacaftor in non-cystic fibrosis bronchiectasis patients with a single pathogenic CFTR mutation: a retrospective cohort analysis.

Papadakis L et al.

Erj Open Research, 2025

41189580 (PubMed )
Supplement: 00007-2025.SUPPLEMENT.pdf

When 25% Feels Like 100%: Confronting Recurrent Cystic Fibrosis Risk Across Consecutive Pregnancies.

Dasgupta S et al.

Cureus, 2025

General Trends in the Calnexin-Dependent Expression and Pharmacological Rescue of Clinical CFTR Variants.

Tedman A et al.

Biorxiv : the Preprint Server for Biology, 2025

40964320 (PubMed )
Supplement: media-1.pdf

Identification and Characterization of a Rare Exon 22 Duplication in CFTR in Two Families.

Ahting S et al.

International Journal of Molecular Sciences, 2025

40429633 (PubMed )
Supplement: ijms-26-04487-s001.zip › CFTR2_25September2024.xlsx › CFTR2_variants__genomic_info

Metabolomic profiling of saliva from cystic fibrosis patients.

Caterino M et al.

Scientific Reports, 2025

Cystic fibrosis risk variants confer protection against inflammatory bowel disease.

Yu M et al.

Medrxiv : the Preprint Server for Health Sciences, 2024

39677473 (PubMed )
Supplement: media-1.xlsx › ST3

Exploring Turkey's mosaic of novel variants and complex alleles in cystic fibrosis genetics.

Yıldız CA et al.

Pediatric Pulmonology, 2024

Next-Generation Sequencing Infertility Panel in Turkey: First Results.

Ikbal Atli E et al.

Balkan Journal of Medical Genetics : Bjmg, 2024

Effect of the Complex Allele p.[Ile148Thr;Ile1023_Val1024del] in Cystic Fibrosis and Tracing of a Founder Effect in Mexican Families.

Mendiola-Vidal NG et al.

Life (basel, Switzerland), 2024

Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA.

Cromwell EA et al.

The European Respiratory Journal, 2024

39227072 (PubMed )
Supplement: ERJ-01146-2024.Supplement.pdf

Phenotypic Evaluation of Rare Cystic Fibrosis Transmembrane Conductance Regulator Mutation Combinations in People with Cystic Fibrosis in Queensland, Australia.

Evans IES et al.

Journal of Clinical Medicine, 2024

CFTR complex alleles and phenotypic variability in cystic fibrosis disease.

El-Seedy A et al.

Cellular and Molecular Biology (noisy-le-grand, France), 2024

Cystic fibrosis transmembrane conductance regulator (CFTR) variants and CFTR function in patients with pancreatitis.

Ooi CY et al.

Pancreatology : Official Journal of the International Association of Pancreatology (iap) ... [et Al.], 2024

Reply to: Cystic fibrosis transmembrane conductance regulator (CFTR) variants and CFTR function in patients with pancreatitis.

Melotti P et al.

Pancreatology : Official Journal of the International Association of Pancreatology (iap) ... [et Al.], 2024

A mathematical model of ENaC and Slc26a6 regulation by CFTR in salivary gland ducts.

Su S et al.

American Journal of Physiology. Gastrointestinal and Liver Physiology, 2024

CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants.

Angyal D et al.

Pancreatology : Official Journal of the International Association of Pancreatology (iap) ... [et Al.], 2024

Mutational spectrum of CFTR in cystic fibrosis patients with gastrointestinal and hepatobiliary manifestations.

Waheed N et al.

Molecular Biology Reports, 2024

Benchmarking AlphaMissense Pathogenicity Predictions Against Cystic Fibrosis Variants.

McDonald EF et al.

Biorxiv : the Preprint Server for Biology, 2024

37873426 (PubMed )
Supplement: media-2.xlsx › Sheet1

ClinGen guidance for use of the PP1/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification.

Biesecker LG et al.

American Journal of Human Genetics, 2024

38103548 (PubMed )
Supplement: mmc2.pdf

Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants.

McDonald EF et al.

Plos One, 2024

38271453 (PubMed )
Supplement: pone.0297560.s008.xlsx › Sheet1

The Effect of Complex Alleles of the CFTR Gene on the Clinical Manifestations of Cystic Fibrosis and the Effectiveness of Targeted Therapy.

Krasnova M et al.

International Journal of Molecular Sciences, 2023

Identification of cystic fibrosis transmembrane conductance regulator gene (CFTR) variants: A retrospective study on the western and southern regions of Saudi Arabia.

Almaghamsi T et al.

Saudi Medical Journal, 2023

A comprehensive review of cystic fibrosis in Africa and Asia.

Abubakar Bobbo K et al.

Saudi Journal of Biological Sciences, 2023

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in People with Cystic Fibrosis from the U.S. Patient Registry.

Salinas DB et al.

Annals of the American Thoracic Society, 2023

Rescue of Rare CFTR Trafficking Mutants Highlights a Structural Location-Dependent Pattern for Correction.

Zacarias S et al.

International Journal of Molecular Sciences, 2023

Lipidomic alterations in human saliva from cystic fibrosis patients.

Caterino M et al.

Scientific Reports, 2023

36635275 (PubMed )
Supplement: 41598_2022_24429_MOESM2_ESM.xlsx › Table_1S

The burden of cystic fibrosis in North Africa.

El Makhzen N et al.

Frontiers in Genetics, 2023

Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis.

Conti J et al.

Children (basel, Switzerland), 2022

Trikafta-Extending Its Success to Less Common Mutations.

Bentur L et al.

Journal of Personalized Medicine, 2022

G378X-I148T CFTR variant: A new complex allele in a cystic fibrosis newborn with pancreatic insufficiency.

Terlizzi V et al.

Molecular Genetics & Genomic Medicine, 2022

Modulator Therapy in Cystic Fibrosis Patients with cis Variants in F508del Complex Allele: A Short-Term Observational Case Series.

Terlizzi V et al.

Journal of Personalized Medicine, 2022

Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience.

Bianchimani C et al.

International Journal of Neonatal Screening, 2022

C FTR variants are associated with chronic bronchitis in smokers.

Saferali A et al.

The European Respiratory Journal, 2022

1–50 of 308 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."